Qiaomei Ren - Search Results

Year	Number of Results
2003	1
2004	1
2005	3
2006	4
2008	1
2009	2
2010	2
2011	6
2012	4
2013	7
2014	4
2015	8
2016	9
2017	13
2018	10
2019	6
2020	7
2021	6
2022	16
2023	10
2024	10

1

Acinetobacter Metabolism in Infection and Antimicrobial Resistance.

Ren X, Palmer LD. Ren X, et al. Infect Immun. 2023 Jun 15;91(6):e0043322. doi: 10.1128/iai.00433-22. Epub 2023 May 16. Infect Immun. 2023. PMID: 37191522 Free PMC article. Review.

2

Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve.

Li C, Qiao Y, Jiang X, Liu L, Zheng Y, Qiu Y, Cheng C, Zhou F, Zhou Y, Huang W, Ren X, Wang Y, Wang Z, Chinnaiyan AM, Ding K. Li C, et al. Among authors: ren x. J Med Chem. 2023 Sep 14;66(17):12432-12445. doi: 10.1021/acs.jmedchem.3c00912. Epub 2023 Aug 21. J Med Chem. 2023. PMID: 37605297 Free PMC article.

3

Targeting EGFR^L858R/T790M and EGFR^{L858R/T790M/C797S} resistance mutations in NSCLC: Current developments in medicinal chemistry.

Lu X, Yu L, Zhang Z, Ren X, Smaill JB, Ding K. Lu X, et al. Among authors: ren x. Med Res Rev. 2018 Sep;38(5):1550-1581. doi: 10.1002/med.21488. Epub 2018 Jan 26. Med Res Rev. 2018. PMID: 29377179 Review.

4

A novel photocaged B-Raf^V600E inhibitor toward precise melanoma treatment.

Chen Z, Ke R, Song Z, Zhou Y, Ren X, Huang W, Wang Z, Ding K. Chen Z, et al. Among authors: ren x. Bioorg Med Chem Lett. 2022 May 15;64:128683. doi: 10.1016/j.bmcl.2022.128683. Epub 2022 Mar 17. Bioorg Med Chem Lett. 2022. PMID: 35307569

5

Small-molecule BET inhibitors in clinical and preclinical development and their therapeutic potential.

Yu L, Wang Z, Zhang Z, Ren X, Lu X, Ding K. Yu L, et al. Among authors: ren x. Curr Top Med Chem. 2015;15(8):776-94. doi: 10.2174/1568026615666150302110135. Curr Top Med Chem. 2015. PMID: 25732788 Review.

6

Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.

Li Y, Lu X, Ren X, Ding K. Li Y, et al. Among authors: ren x. J Med Chem. 2015 Apr 23;58(8):3287-301. doi: 10.1021/jm5012319. Epub 2015 Jan 21. J Med Chem. 2015. PMID: 25569119 Review.

7

GZD824 overcomes FGFR1-V561F/M mutant resistance in vitro and in vivo.

Jiang K, Tang X, Guo J, He R, Chan S, Song X, Tu Z, Wang Y, Ren X, Ding K, Zhang Z. Jiang K, et al. Among authors: ren x. Cancer Med. 2021 Jul;10(14):4874-4884. doi: 10.1002/cam4.4041. Epub 2021 Jun 10. Cancer Med. 2021. PMID: 34114373 Free PMC article.

8

Targeting the Non-Catalytic Functions: a New Paradigm for Kinase Drug Discovery?

Wang Z, Huang W, Zhou K, Ren X, Ding K. Wang Z, et al. Among authors: ren x. J Med Chem. 2022 Feb 10;65(3):1735-1748. doi: 10.1021/acs.jmedchem.1c01978. Epub 2022 Jan 9. J Med Chem. 2022. PMID: 35000385

9

N-(3-Ethynyl-2,4-difluorophenyl)sulfonamide Derivatives as Selective Raf Inhibitors.

Li Y, Cheng H, Zhang Z, Zhuang X, Luo J, Long H, Zhou Y, Xu Y, Taghipouran R, Li D, Patterson A, Smaill J, Tu Z, Wu D, Ren X, Ding K. Li Y, et al. Among authors: ren x. ACS Med Chem Lett. 2015 Mar 18;6(5):543-7. doi: 10.1021/acsmedchemlett.5b00039. eCollection 2015 May 14. ACS Med Chem Lett. 2015. PMID: 26005530 Free PMC article.

10

Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemia.

Liu W, Bai Y, Zhou L, Jin J, Zhang M, Wang Y, Lin R, Huang W, Ren X, Ma N, Zhou F, Wang Z, Ding K. Liu W, et al. Among authors: ren x. Eur J Med Chem. 2024 Jan 15;264:115974. doi: 10.1016/j.ejmech.2023.115974. Epub 2023 Nov 19. Eur J Med Chem. 2024. PMID: 38007910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

123 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year